Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00857844 · ClinicalTrials.gov registry record

Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers

A clinical trial, sponsored by Northwestern University.

Completed
Registry status
207
Enrollment target

NCT00857844 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 207 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00857844 has completed, sponsored by Northwestern University.

COMPLETED
Registry status
207 participants
Enrollment target

Study Summary

The purpose of this study is to determine the relationship between genomic variants of components of the renin-angiotensin system and the development of kidney problems due to Calcineurin-inhibitors post liver transplant.Also the investigator will evaluate the relationship between chronic renal failure post liver transplant and the risk of death. A sample of blood and urine wil be examined to see how the patient's genes are arranged in order to determine the difference in genes between people which may explain who will develop chronic renal failure after having received a liver transplant. The results may help us classify patients according to their risk and allow us to target their treatment to their individual need. In addition, it may ultimately lead to treatments that slows or prevents the development of chronic rejection.

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2007-07
Est. Completion 2012-05

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT00857844

The ClinicalTrials.gov registry entry for NCT00857844 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00857844 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00857844 about?

NCT00857844 is a clinical study titled "Genetic Predisposition-Chronic Nephrotoxicity From CI-Liver Transplant Recipients-Potential Correlation-Urinary Biomarkers". The purpose of this study is to determine the relationship between genomic variants of components of the renin-angiotensin system and the development of kidney problems due to Calcineurin-inhibitors post liver transplant.Also the investigator will evaluate the relationship between chronic renal fail...

What is the current status of trial NCT00857844?

This trial is currently completed. The enrollment target is 207 participants. The study started on 2007-07. Estimated completion is 2012-05.

Who is sponsoring clinical trial NCT00857844?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.